Impact of renal insufficiency on short- and long-term outcomes after cardiac surgery

American Heart Journal

Volumn 148, Issue 3, 2004, Pages 430-438

  Lok, Charmaine E ^a,b,d   Austin, Peter C ^a   Wang, Hua ^a   Tu, Jack V ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; COMORBIDITY; CORONARY ARTERY BYPASS SURGERY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; FEMALE; HEART SURGERY; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE REGRESSION; POPULATION RESEARCH; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVASCULARIZATION; RISK FACTOR;

AGED; ANALYSIS OF VARIANCE; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HOSPITAL MORTALITY; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 4644295713     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.12.042     Document Type: Article

References (43)

1. Levey A.S., Beto J.A., Coronado B.E., et al. Controlling the epidemic of cardiovascular disease in chronic renal disease what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 32:1998;853-906
2. Muntner P., He J., Hamm L., et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 13:2002;745-753
3. Henry RM, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002;62:1402-7
4. Fried L.P., Kronmal R.A., Newman A.B., et al. Risk factors for 5-year mortality in older adults the Cardiovascular Health Study. JAMA. 279:1998;585-592
5. Jones C.A., McQuillan G.M., Kusek J.W., et al. Serum creatinine levels in the US population Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 32:1998;992-999
6. Culleton B.F., Larson M.G., Evans J.C., et al. Prevalence and correlates of elevated serum creatinine levels the Framingham Heart Study. Arch Intern Med. 159:1999;1785-1790
7. Garg A.X., Kiberd B.A., Clark W.F., et al. Albuminuria and renal insufficiency prevalence guides population screening results from the NHANES III. Kidney Int. 61:2002;2165-2175
8. Duncan L., Heathcote J., Djurdjev O., et al. Screening for renal disease using serum creatinine who are we missing? Nephrol Dial Transplant. 16:2001;1042-1046
9. Clase C.M., Garg A.X., Kiberd B.A. Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. J Am Soc Nephrol. 13:2002;2811-2816
10. Dialysis and renal transplantation: Canadian Organ Replacement Register. Ottawa, Ontario: Canadian Institute for Health Information; 2000
11. US renal data system: USRDS 2000 annual data report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases; 2000
12. Foley R.N., Parfrey P.S., Sarnak M.J. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 9:(12 Suppl):1998;S16-23
13. Herzog C.A., Ma J.Z., Collins A.J. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 106:2002;2207-2211
14. Szczech L.A., Reddan D.N., Owen W.F., et al. Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int. 60:2001;292-299
15. Anderson R.J., O'Brien M., MaWhinney S., et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery VA Cooperative Study #5. Kidney Int. 55:1999;1057-1062
16. Grover F.L., Hammermeister K.E., Burchfiel C. Initial report of the Veterans Administration Preoperative Risk Assessment Study for Cardiac Surgery. Ann Thorac Surg. 50:1990;12-26
17. Hammermeister K.E., Johnson R., Marshall G., et al. Continuous assessment and improvement in quality of care a model from the Department of Veterans Affairs Cardiac Surgery. Ann Surg. 219:1994;281-290
18. O'Connor G.T., Plume S.K., Olmstead E.M., et al. Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery Northern New England Cardiovascular Disease Study Group. Circulation. 85:1992;2110-2118
19. Shroyer A.L., Grover F.L., Edwards F.H. 1995 coronary artery bypass risk model the Society of Thoracic Surgeons Adult Cardiac National Database. Ann Thorac Surg. 65:1998;879-884
20. Mangano C.M., Diamondstone L.S., Ramsay J.G., et al. Renal dysfunction after myocardial revascularization risk factors, adverse outcomes, and hospital resource utilization: the Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 128:1998;194-203
21. Liu J.Y., Birkmeyer N.J., Sanders J.H., et al. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery Northern New England Cardiovascular Disease Study Group. Circulation. 102:2000;2973-2977
22. Chertow G.M., Lazarus J.M., Christiansen C.L., et al. Preoperative renal risk stratification. Circulation. 95:1997;878-884
23. Nakayama Y., Sakata R., Ura M., et al. Long-term results of coronary artery bypass grafting in patients with renal insufficiency. Ann Thorac Surg. 75:2003;496-500
24. Szczech L.A., Best P.J., Crowley E., et al. Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation. 105:2002;2253-2258
25. Tu J.V., Jaglal S.B., Naylor C.D. Multicenter validation of a risk index for mortality, intensive care unit stay, and overall hospital length of stay after cardiac surgery Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. Circulation. 91:1995;677-684
26. Naylor C.D., Baigrie R.S., Goldman B.S., et al. Assessment of priority for coronary revascularisation procedures Revascularisation Panel and Consensus Methods Group. Lancet. 335:1990;1070-1073
27. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 45:1992;613-619
28. Ghali W.A., Rothwell D.M., Quan H., et al. A Canadian comparison of data sources for coronary artery bypass surgery outcome "report cards" Am Heart J. 140:2000;402-408
29. Tu J.V., Naylor C.D. Coronary artery bypass mortality rates in Ontario a Canadian approach to quality assurance in cardiac surgery. Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. Circulation. 94:1996;2429-2433
30. Naylor CD, Rothwell DM, Tu J. Outcomes of the provincial adult cardiac care network of Ontario: outcomes of coronary artery bypass in Ontario. In: Naylor CD, Slaughter PM, editors. Cardiovascular health and services in Ontario: an ICES atlas. Toronto: Institute for Clinical Evaluative Sciences; 1999. p. 189-98
31. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41
32. Clough RA, Leavitt BJ, Morton JR, et al. The effect of comorbid illness on mortality outcomes in cardiac surgery. Arch Surg 2002:428-32
33. Abel R.M., Buckley M.J., Austen W.G., et al. Etiology, incidence, and prognosis of renal failure following cardiac operations results of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc Surg. 71:1976;323-333
34. Dobernak R.D., Reiser M.P., Lillehie C.W. Acute renal failure and open heart surgery utilizing extracorporeal circulation and total body perfusion analysis of 1000 patients. J Thorac Cardiovasc Surg. 43:1962;441-452
35. Higgins T.L., Estafanous F.G., Loop F.D., et al. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients a clinical severity score. JAMA. 267:1992;2344-2348
36. Gardner S.C., Grunwald G.K., Rumsfeld J.S., et al. Risk factors for intermediate-term survival after coronary artery bypass grafting. Ann Thorac Surg. 72:2001;2033-2037
37. Mark D.B. Implications of cost in treatment selection for patients with coronary heart disease. Ann Thorac Surg. 61:(2 Suppl):1996;S12-15
38. Sergeant P., Blackstone E., Meyns B. Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG KU Leuven Coronary Surgery Program. Eur J Cardiothorac Surg. 12:1997;1-19
39. Jones R.H., Hannan E.L., Hammermeister K.E., et al. Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery the Working Group Panel on the Cooperative CABG Database Project. J Am Coll Cardiol. 28:1996;1478-1487
40. Vanholder R., Ringoir S. Infectious morbidity and defects of phagocytic function in end-stage renal disease a review. J Am Soc Nephrol. 3:1993;1541-1554
41. Perrone R.D., Madias N.E., Levey A.S. Serum creatinine as an index of renal function new insights into old concepts. Clin Chem. 38:1992;1933-1953
42. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 130:1999;461-470
43. Bostom A.G., Kronenberg F., Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol. 13:(8):2002;2140-2144